Reading PET scans at 70 mph

As though there weren't enough ways to be wrong, doctors reading medical images now have a new way to fuck up the quality of your health care: Mobile MIM, the first iPhone app FDA-approved for "viewing images [such as CT, PET and MRI scans] and making medical diagnoses."

How big is that iPhone display, about four inches by two inches? Perfect. Why have hospitals been wasting all that film making such huge pictures when all that was ever necessary was something the size of a baseball card?

The FDA clearly states that the app is "indicated for use only when there is no access to a workstation." There's no workstation in the car, on the freeway, at home, out to dinner, at the ballgame, in the bathroom—all the many places doctors will be viewing our films with this app. Why? Because they can.

Will you ever know that the mistake in your diagnosis was made by a radiologist who read your films while flying down the freeway or sitting on the toilet? Probably not.

PREDICTIONS

Reluctantly, I can already see the following events unfolding:

-- One doctor will abuse the shit out of this luxury and make dozens of misdiagnoses with it because he wasn't paying enough attention, exposing widespread abuse of the app.
-- Similar apps will receive FDA approval until one goes too far, maybe it will claim to remotely perform a prostate exam.
-- Doctors will deflect criticism of diagnostic apps by playing the "We're smart and know better" card until it becomes impossible to defend. Then they'll throw up their hands and say "FDA approved, how should we know it wouldn't work?"

Apps are great for playing Scrabble knock-offs, not for making life-altering diagnoses.

By Ross Bonander
Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap